Quince Therapeutics, Inc. (QNCX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.68 | -28.2% |
| 2024 | $-1.31 | -56.0% |
| 2023 | $-0.84 | +45.5% |
| 2022 | $-1.54 | +49.2% |
| 2021 | $-3.03 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.68 | -28.2% |
| 2024 | $-1.31 | -56.0% |
| 2023 | $-0.84 | +45.5% |
| 2022 | $-1.54 | +49.2% |
| 2021 | $-3.03 | — |